DK0612242T3 - Anvendelse af ren S(+)-isomer af fluoxetin til fremstilling af et medikament mod migræne - Google Patents

Anvendelse af ren S(+)-isomer af fluoxetin til fremstilling af et medikament mod migræne

Info

Publication number: DK0612242T3
Authority: DK; Denmark
Prior art keywords: fluoxetine; pure; isomer; compositions; methods
Prior art date: 1991-11-15

Application number

DK92906545T

Other languages

Danish (da)

English (en)

Inventor

James W Young

Timothy J Barberich

Original Assignee

Sepracor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-15

Filing date

1992-02-05

Publication date

2003-10-20

1992-02-05 Application filed by Sepracor Inc filed Critical Sepracor Inc

2003-10-20 Application granted granted Critical

2003-10-20 Publication of DK0612242T3 publication Critical patent/DK0612242T3/da

Links

229960002464 fluoxetine Drugs 0.000 title abstract 4
RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 title abstract 3
208000019695 Migraine disease Diseases 0.000 title abstract 2
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
206010027599 migraine Diseases 0.000 title 1
239000000203 mixture Substances 0.000 abstract 3
208000002193 Pain Diseases 0.000 abstract 2
208000000094 Chronic Pain Diseases 0.000 abstract 1
206010027603 Migraine headaches Diseases 0.000 abstract 1
208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
230000002411 adverse Effects 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940005513 antidepressants Drugs 0.000 abstract 1
239000002830 appetite depressant Substances 0.000 abstract 1
230000008517 inhibition of serotonin uptake Effects 0.000 abstract 1
210000002569 neuron Anatomy 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
230000004800 psychological effect Effects 0.000 abstract 1
230000000862 serotonergic effect Effects 0.000 abstract 1
231100000331 toxic Toxicity 0.000 abstract 1
230000002110 toxicologic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Addiction (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

DK92906545T 1991-11-15 1992-02-05 Anvendelse af ren S(+)-isomer af fluoxetin til fremstilling af et medikament mod migræne DK0612242T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US79303691A	1991-11-15	1991-11-15
PCT/US1992/000888 WO1993009769A1 (fr)	1991-11-15	1992-02-05	Procedes et compositions a base de fluoxetine isomere s(+) pur

Publications (1)

Publication Number	Publication Date
DK0612242T3 true DK0612242T3 (da)	2003-10-20

Family

ID=25158891

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92906545T DK0612242T3 (da)	1991-11-15	1992-02-05	Anvendelse af ren S(+)-isomer af fluoxetin til fremstilling af et medikament mod migræne

Country Status (9)

Country	Link
EP (2)	EP0612242B1 (fr)
JP (2)	JPH07500812A (fr)
AT (1)	ATE244563T1 (fr)
AU (2)	AU1373692A (fr)
CA (1)	CA2123704C (fr)
DE (1)	DE69233124T2 (fr)
DK (1)	DK0612242T3 (fr)
ES (1)	ES2197144T3 (fr)
WO (1)	WO1993009769A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1738753E (pt) *	1993-06-28	2008-06-19	Wyeth Corp	Novos tratamentos utilizando derivados de fenetilamina
ES2082723B1 (es) *	1994-07-20	1996-10-01	Lilly Sa	Formulacion farmaceutica de fluoxetina en forma dispersable.
US6548084B2 (en)	1995-07-20	2003-04-15	Smithkline Beecham Plc	Controlled release compositions
ES2103682B1 (es) *	1995-09-20	1998-04-01	Lilly Sa	Composicion farmaceutica oral de fluoxetina, solida y con caracteristicas organolepticas mejoradas.
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
US6846957B2 (en)	2002-11-22	2005-01-25	Board Of Regents, The University Of Texas System	Synthesis of 3-aminomethyl-1-propanol, a fluoxetine precursor
CN111643475A (zh) *	2020-07-20	2020-09-11	华益药业科技(安徽)有限公司	一种氟西汀胶囊生产工艺

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA817863B (en) *	1980-11-14	1983-06-29	Lilly Co Eli	(-)n-methyl-3-(2-methylphenoxy)-3-phenylpropylamnie,antidepressant

1992
- 1992-02-05 WO PCT/US1992/000888 patent/WO1993009769A1/fr not_active Ceased
- 1992-02-05 EP EP92906545A patent/EP0612242B1/fr not_active Expired - Lifetime
- 1992-02-05 AT AT92906545T patent/ATE244563T1/de not_active IP Right Cessation
- 1992-02-05 DE DE69233124T patent/DE69233124T2/de not_active Expired - Fee Related
- 1992-02-05 DK DK92906545T patent/DK0612242T3/da active
- 1992-02-05 JP JP4506297A patent/JPH07500812A/ja active Pending
- 1992-02-05 EP EP02003532A patent/EP1208838A3/fr not_active Withdrawn
- 1992-02-05 ES ES92906545T patent/ES2197144T3/es not_active Expired - Lifetime
- 1992-02-05 AU AU13736/92A patent/AU1373692A/en not_active Abandoned
- 1992-02-05 CA CA002123704A patent/CA2123704C/fr not_active Expired - Fee Related
1997
- 1997-04-17 AU AU18917/97A patent/AU1891797A/en not_active Abandoned
2003
- 2003-08-28 JP JP2003304079A patent/JP2004002474A/ja active Pending

Also Published As

Publication number	Publication date
JPH07500812A (ja)	1995-01-26
EP1208838A3 (fr)	2003-07-09
EP0612242A4 (en)	1997-01-15
JP2004002474A (ja)	2004-01-08
ATE244563T1 (de)	2003-07-15
DE69233124T2 (de)	2004-02-19
AU1373692A (en)	1993-06-15
DE69233124D1 (de)	2003-08-14
EP0612242B1 (fr)	2003-07-09
WO1993009769A1 (fr)	1993-05-27
AU1891797A (en)	1997-06-19
EP1208838A2 (fr)	2002-05-29
EP0612242A1 (fr)	1994-08-31
CA2123704C (fr)	2003-01-21
ES2197144T3 (es)	2004-01-01
CA2123704A1 (fr)	1993-05-27

Similar Documents

Publication	Publication Date	Title
DE60216830D1 (de)	2007-02-01	Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
DK0415613T3 (da)	1994-10-10	Anvendelse af sertralin til behandling af præmatur ejakulation
DK1346041T3 (da)	2007-07-02	Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
DE59109222D1 (de)	2001-11-22	Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
DE60134453D1 (de)	2008-07-31	Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten
EA200200392A1 (ru)	2002-08-29	Способ получения экстракта из растения рода trichocaulon или рода hoodia, экстракт, порошковый материал и композиция на его основе и их применение для производства медикамента для лечения, профилактики или преодоления ожирения и/или подавления аппетита
NO941065L (no)	1994-03-23	Fremgangsmåte og blandinger for behandling av cerebral lammelse
AR026084A1 (es)	2002-12-26	Heterociclos de nitrogeno biciclicos
CY1114645T1 (el)	2016-10-05	Συνθεση αλατος φεντανυλης για ρινικη χορηγηση
TW200607512A (en)	2006-03-01	Use of optically pure (S,S)-reboxetine in the manufacture of a medicament for the treatment or prevention of migraine headaches
ATE450269T1 (de)	2009-12-15	Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
NO952418D0 (no)	1995-06-16	Antipyretiske og analgetiske metoder og sammensetninger som inneholder optisk ren R-ketorolak
DK1678172T3 (da)	2010-04-06	Azabicykliske forbindelser til lindring af smerte og behandling af sygdomme i centralnervesystemet
RU2004110041A (ru)	2005-03-10	Фармацевтическая композиция, содержащая габапентин или его аналог и альфа-аминоамид, и ее применение в качестве анальгетика
DE69210654D1 (de)	1996-06-20	Verwendung von Tomoxetine zur Behandlung von Funktionsstörungen der niedrigen Harnwege
EP0612242A4 (en)	1997-01-15	Methods and compositions utilizing pure s(+) isomer fluoxetine.
BG105218A (en)	2001-11-30	The use of optically pure (+) norcisapride for treating gastro-esophageal reflux disease
NO20030155L (no)	2003-03-13	Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DE69626916D1 (de)	2003-04-30	Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten
DK0415612T3 (da)	1993-12-13	Anvendelse af sertralin til behandling af afhængigheder af kemiske stoffer
ATE506348T1 (de)	2011-05-15	Neue benzoylpiperidinverbindungen
ATE353887T1 (de)	2007-03-15	Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze
UY27037A1 (es)	2003-06-30	Composición de apomorfina para tratar la disfunción sexual con niveles específicos de concentración en plasma
ECSP003554A (es)	2000-10-24	Inhibidores altamente selectivos para la recuperacion de la norepinefrina y metodos para utilizar los mismos
MX9704887A (es)	1998-06-30	Composiciones farmaceuticas para el tratamiento de trastornos depresivos.